Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Prophylaxis
Prophylaxis in horses refers to the preventive measures and strategies implemented to protect equine health by reducing the risk of disease occurrence. These measures can include vaccinations, parasite control, nutrition management, and biosecurity practices. Vaccinations help to stimulate the horse's immune system to protect against specific infectious diseases. Parasite control programs aim to minimize the impact of internal and external parasites through strategic deworming and environmental management. Nutrition management ensures that horses receive balanced diets that support their overall health and immune function. Biosecurity practices involve procedures to prevent the introduction and spread of infectious agents within equine populations. This page gathers peer-reviewed research studies and scholarly articles that explore various prophylactic approaches, their implementation, and their effectiveness in maintaining equine health.
[The economic evaluation of vaccination against infectious cough in horses using the cost-benefit analysis]. Approximately 40% of all horses in the Federal Republic of Germany had infectious respiratory disease in 1982. Although an expert vaccine prophylaxis confers a reliable protection, conventional therapy is preferred over vaccination because of the cost. The cost/effect analysis carried out in this investigation demonstrates that vaccination should be favoured also for economic reasons. Based on the individual animal immune prophylaxis saves the horse owner at least 415 DM per year. This analysis did not take into account the danger of a transmission to man and related infection chains of viruse...
[Efficient drug forms and the means for using them in the intensive raising of animals]. Stated is the use of promising therapeutic formulae that produce prophylactic, metaphylactic, and curative effects at lower input of labour and handling, inciting lower unrest with animals, belonging chiefly to the type of the so-called 'therapeutic systems'. Particular attention is paid to drugs for programmed, continuous, and checkable release of the active ingredients in compliance with what is needed at the time (sustained release forms)-type OROS (oral osmotic system), type 'liquid reservoir', type 'glass cylinders', tablets and boluses of higher relative weight, or multilayer and mosaic ...
Activity of closantel in the prevention of Gasterophilus and Strongylus vulgaris larval infections in equine foals and yearlings. Two controlled tests were conducted in equine foals and yearlings to determine the optimal oral dosage and the duration of activity of closantel for the prevention of Gasterophilus spp larval infections. Additional data were collected on the activity of closantel against Strongylus vulgaris larval infections. In experiment 1, 12 foals and 12 yearlings were equally allocated to 4 experimental groups, and were given oral treatments with closantel at dosages of 0 (nontreated controls), 2, 5, or 8 mg/kg of body weight every 2 months during bot season. The foals and yearlings were allowed to graze ...
Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. Serum levels of equine-botulism antitoxin to toxin types A, B, and E were measured in four type-A botulism patients who had received equine-botulism antitoxin. High circulating levels capable of neutralizing in excess of 1 X 10(8), 9 X 10(7), and 6 X 10(6) 50% mouse lethal doses of toxin of types A, B, and E, respectively, were detected. There was little depletion of type-A antitoxin even though two of the patients had circulating type-A toxin before treatment. The half-life for antitoxin persistence for one patient was calculated as being 6.5, 7.6, and 5.3 days for antitoxin types A, B, and E...
[Current virus diseases in horses. Diseases in foals and respiratory tract infections]. At the moment, horse praxis is confronted by two disease complexes which are difficult to fight against as well in prophylaxis as in therapy, but which get an increasing importance. First they concern virus infections of the foals and second primary virus-caused respiratory diseases. Foals get infected during the embryonal/fetal development, in the perinatal or postnatal period. Normally the infection is caused by latent infected, clinical healthy mares, or in the postnatal period by ubiquitous, normally opportunistic socalled problem-viruses, i.e. equine herpes-viruses 1 and 2, rota-, corona-...
Clinical observations on an outbreak of strangles. An outbreak of strangles, which occurred during the spring, summer and fall of 1980 on a Standardbred stud farm in eastern Alberta is described. The infective organism, Streptococcus equi, may have been introduced by an outside mare that was brought to the stud for breeding. All of the groups of horses on the farm were affected. For the most part, the disease was allowed to run its natural course. Only severely affected individuals were treated. During the outbreak, the foals were prophylactically treated with penicillin to prevent them from contracting the disease. Ten horses died of complica...
The use of equine anti-endotoxin hyperimmune serum in the treatment of septic arthritis in foals. Three thoroughbred foals were treated with anti-endotoxin hyperimmune serum. The serum was injected into the affected joint spaces. Two of the foals made a complete recovery.
Effect of isometamidium on infections by Trypanosoma vivax and T. evansi in experimentally-infected animals. Assays dealing with the therapeutic and prophylactic activity of isometamidium on experimental infections by Trypanosoma vivax and T. evansi were carried out. The drug was found to be highly effective against T. vivax infection in sheep and cattle in which periods of protection ranging from 118 to 195 days were achieved. No complete effects against infection by T. evansi were observed. The drug was well tolerated in sheep and cattle while side-effects were noted in treated mares. It was concluded that isometamidium could be used to prevent damage and economical losses caused by T. vivax in Ven...
Equine immunology 4: vaccines and antisera. This paper attempts to relate the practicalities of vaccine development to the ideals which should be aimed for in a new vaccine. The type of immune response induced is dependent upon the nature of the antigen in the vaccine and the site and timing of its presentation to the immune system. In this respect the influence of age, maternal immunity and antigenic competition are discussed. The possible side effects associated with vaccination are defined and vaccines which are currently available for horses are reviewed. These vaccines are mostly for the prevention of respiratory disease. Finally, ...
Attempted reconstitution of a foal with primary severe combined immunodeficiency. A foal with primary severe combined immunodeficiency, diagnosed within the first two weeks of life, was maintained with its dam in semi-isolation. The foal received continuous prophylactic antibiotic therapy, plasma from a sibling hyperimmunised with equine adenovirus vaccine, and intensive general nursing care. A full sibling female was selected as a bone marrow donor on the basis of red blood cell cross-matching and mixed lymphocyte reactions. Cyclophosphamide was given before two bone marrow transfusions at 35 and 73 days of age. To prevent graft versus host disease graft versus host diseas...
Chronic obstructive pulmonary disease in the horse. 2: Therapy. The therapy of equine chronic obstructive pulmonary disease (COPD) essentially entails minimising the horse's exposure to the aetiological antigens which are predominantly thermophilic actinomycetes and moulds occurring in hay and straw. This can be achieved, for example, by keeping affected horses permanently out of doors, or when stabled, using shredded paper, wood shavings or peat moss as bedding and feeding a complete cubed diet. There should be no supplementary hay feeding apart from dust-free vacuum-packed hay. Applying such measures generally allows horses to become asymptomatic in seve...
Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). Forty ponies immunized with inactivated virus vaccine containing A/equine/Miami/63 (H3N8) virus and six unvaccinated, seronegative ponies were experimentally challenged with a representative of recent equine H3N8 virus isolates, A/equine/Newmarket/79. All unvaccinated ponies became infected as judged by virus excretion, febrile responses and antibody responses, but only two of the vaccinated ponies were fully protected. Pre-challenge antibody levels to A/Newmarket/79 virus detected by single radial haemolysis (SRH) correlated well with the degree of clinical protection but the levels required ...
[Genetic research in the field of reproductive pathology and genetic prophylaxis in agricultural animals in the Socialist Republic of Romania]. The paper presents the results of some genetic studies accomplished in Romania in the field of pathology of reproduction in domestic animals (pseudohermaphroditism in horses, testicular hypoplasia in he-goats, intersexuality in pigs, freemartinism and genital infantilism in cattle). Also, the use of the cytogenetic test in genetic prophylaxis in pigs and cattle was shown. In addition, the methods for detecting genitors with undesirable genes were devised and perspectives for the development of hereditary hygiene discussed.
[Economic importance of protecting draft horses used in forestry against blood-sucking dipterous insects]. The adverse effect of blood-sucking dipterous insects (gadflies, gnats, black flies, midges) was determined and checked, as exerted on the working performance of draft horses working in forests; the possibilities of protecting horses with repellents were studied at the same time. The trial was conducted under field conditions in the territory of the Broumov Forest Establishment in the Náchod and Trutnov districts. A 10% water emulsion of the repellent, diethyltoluamide, was used; the horses were treated with the emulsion in a 24-hour interval. Over the seventy working days from the 1st of Jul...
Reconstitution of primary, severe, combined immunodeficiency in man and horse. Severe combined immunodeficiency disease (SCID) in foals is the only known animal model for the autosomal recessive form of primary SCID in man. A major requirement in the treatment of SCID is the maintenance of the patient in a disease free state until definitive therapy can be undertaken. This paper reviews the current status of prophylactic and definitive therapy in man and the horse. Particular emphasis is placed on the methods of reconstitution available, involving foetal tissues and bone marrow.
Respiratory tract immune response to microbial pathogens. Effective resistance to respiratory tract infection depends principally on specific immunity on mucosal surfaces of the upper or lower respiratory tract. Respiratory tract immune response comprises antibody and cell-mediated systems and may be induced most readily by surface presentation of replicating agents but can result from parenteral or local presentation of highly immunogenic antigens. Upper and lower respiratory tract systems differ in immunologic competence, with the lungs having a greater inventory of protective mechanisms than the trachea or nose. Several effective vaccines have bee...
Duration of maternally derived immunity to tetanus and response in newborn foals given tetanus antitoxin. Serum tetanus antitoxin (TAT) concentrations were measured in a group of 30 foals from birth to 4 months of age. Five of 30 foals (16.6%) had serum titers less than 0.01 IU of TAT/ml by 1 month of age. At 2 months of age, 17 of 28 foals (60.7%) had titers less than 0.01 IU/ml. By 3 months of age, 22 of 29 (75.5%) foals tested had titers of less than 0.01 IU/ml. At the age of 4 months, 24 of 29 foals (82.1%) had titers of less than 0.01 IU/ml. The TAT given to foals at birth resulted in an immediate increase in titer when circulating antitoxin was absent or minimal. Titers considered protective...
Irradiated larval vaccination of ponies against strongylus vulgaris. Nonimmune pony foals 9 to 12 mo of age were vaccinated with third-stage Strongylus vulgaris larvae (L3) irradiated with 70, 100, or 130 Kr of gamma radiation. Ponies receiving per os inoculations of L3 irradiated with 70 or 100 Kr were protected from the clinical disease and lesions associated with challenge infections of 4,300 L3, when compared to nonvaccinated controls. Similarly, the numbers of worms from the challenging population recovered from successfully vaccinated animals were significantly lower than from nonvaccinated controls. The degree of resistance that develops in individuals c...
